DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
- Description:
Fluorescent β2 adrenoceptor antagonist
![CA200656 CellAura fluorescent β<sub>2</sub> antagonist [(±)-propranolol]](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR4nGP6zwAAAgcBApocMXEAAAAASUVORK5CYII=)
- Description:
Fluorescent 5-HT1A receptor antagonist
- Description:
Fluorescent 5-HT2A receptor antagonist
-
Caffeine (HB2846)
Description:Non-selective, competitive adenosine receptor antagonist / PDE inhibitor
-
-
-
Calphostin C (HB0160)
Description:Potent, selective PKC inhibitor. Also antagonizes the Tcf/β-catenin complex
Purity:>95%
![CA200656 CellAura fluorescent β<sub>2</sub> antagonist [(±)-propranolol]](https://hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/h/b/hb7820-ca200656-image1_1.jpg)
![CA200992 CellAura fluorescent 5-HT<sub>1A</sub> antagonist [NAN-190]](https://hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/h/b/hb7828-ca200992.png)
